ESC 365 - Natural history and prognostic significance of pulmonary hypertension in patients undergoing TAVR for severe aortic stenosis

ESC Premium Access

Natural history and prognostic significance of pulmonary hypertension in patients undergoing TAVR for severe aortic stenosis

Session: TAVI: a new standard for aortic valve replacement?

Topic: Aortic valve disease

Speaker: Doctor B. Alushi (Munich, DE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Brunilda Alushi

Conradia medical prevention, Munich (Germany)

0 follower

4 more presentations in this session

State of the Art: TAVI indications and adoption: a dynamic field

Speaker: Professor B. Prendergast (London, GB)

Thirty-day and long-term outcomes after transcatheter aortic valve implantation from first-in-man to nowadays: 15 years experience of a pioneered center.

Speaker: Professor E. Durand (Rouen, FR)

Worse outcome of patients with normal ejection fraction but low-gradient aortic valve stenosis after transcatheter aortic valve implantation (TAVI)

Speaker: Doctor U. Fischer-Rasokat (Bad Nauheim, DE)

TAVI complications: incidence, trends and management.

Speaker: Professor A. Chieffo (Milan, IT)

Access the full session

TAVI: a new standard for aortic valve replacement?

Speakers: Doctor B. Alushi, Professor B. Prendergast, Professor E. Durand, Doctor U. Fischer-Rasokat, Professor A. Chieffo

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources